FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology and relates to a strain of Mycobacterium tuberculosis 326/18/47, intended for research work in the diagnosis of strains resistant to delamanid.
EFFECT: strain can be used in medicine in evaluating the effectiveness of anti-tuberculosis drugs, disinfectants and creating diagnostic test systems.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING THE GENETIC PREDISPOSITION TO THE DEVELOPMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS MYCOBACTERIUM TUBERCULOSIS IN HIV INFECTION | 2020 |
|
RU2750715C1 |
| COMPOUND 1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-CYCLOHEXYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2825647C1 |
| 5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2705591C1 |
| METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
| METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2805496C1 |
| 1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-PROPYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY IN WITH RESPECT TO MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2824817C1 |
| METHOD FOR MOLECULAR-GENETIC DETECTION OF TUBERCULOSIS MICROBACTERIA RESISTANCE TO ANTITUBERCULAR PREPARATIONS OF SECOND SERIES (FLUOROQUINOLONES, AMINOGLYCOSIDES AND CAPREOMICIN) | 2015 |
|
RU2633507C2 |
| METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
| DIAGNOSTICS METHOD OF SENSITIVITY OF Mycobacterium tuberculosis STRAINS TO INJECTION ANTITUBERCULOUS PREPARATIONS OF RESERVE ROW (AMINOGLYCOSIDES AND CAPREOMYCIN) | 2012 |
|
RU2509158C2 |
| METHOD FOR FORMING A CHEMOTHERAPY REGIMEN FOR PRIMARY INTRATHORACIC TUBERCULOSIS IN CHILDREN FROM TUBERCULOSIS INFECTION CENTERS | 2018 |
|
RU2704816C1 |
